학술논문
6531 POSTER XPD 312 single nucleotide polymorphism (SNP) predicts survival in stage IIIA–B non-small-cell lung cancer (NSCLC) patients (pts) < 59 years (y) treated with chemotherapy followed by surgery
Document Type
Abstract
Author
Source
In EJC Supplements 2007 5(4):367-367
Subject
Language
ISSN
1359-6349